Literature DB >> 20924803

Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies.

Dermot R Doherty1, Elena Pascuet, Andy Ni, Paul Stewart, William Splinter, Régis Vaillancourt.   

Abstract

PURPOSE: In pediatric practice, the official drug label often does not accurately reflect the contemporary use of many drugs prescribed to children. Therefore, clinicians frequently use contemporary drug references as a source of prescribing information instead of national formularies. The objective of this study was to compare drug prescriptions between two national formularies and two commonly used contemporary pediatric reference guidelines in the operating room/postanesthetic care unit (OR/PACU), pediatric intensive care unit (PICU), and neonatal intensive care unit (NICU).
METHODS: We performed a retrospective chart review of patients admitted over a one-month period to the NICU and PICU, and for one week during the same month, we reviewed charts of patients in the OR/PACU. The data collected included patients' demographic information, drugs prescribed, and dosage information. We assessed conformity with two national formularies, the Canadian Compendium of Pharmaceuticals and Specialties (CPS) and France's 2009 Dictionnaire Vidal (Vidal), and two contemporary pediatric references, the Hospital for Sick Children Handbook and Formulary and the Lexi-Comp Pediatric Dosage Handbook.
RESULTS: Across the three clinical units, 59.7% (95% confidence interval [CI] 57.1-62.1%) of prescriptions were identified as being off-label, as defined by the CPS formulary. The odds of having an off-label prescription would have been substantially lower if the contemporary pediatric references (odds ratio [OR] = 0.074; 95% CI 0.065-0.084) or Vidal (OR = 0.70; 95% CI 0.63-0.77) had been used to define the label (both P < 0.001 compared with the CPS).
CONCLUSION: Drugs are less likely to be off-label if prescribed according to a contemporary pediatric reference rather than according to national formularies. Methodologies used to compile contemporary references might serve as templates to inform a drug's official label.

Entities:  

Mesh:

Year:  2010        PMID: 20924803     DOI: 10.1007/s12630-010-9395-0

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  8 in total

1.  Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research.

Authors:  Angela S Czaja; Pamela D Reiter; M Lynn Schultz; Robert J Valuck
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

Review 2.  Two decades of off-label prescribing in children: a literature review.

Authors:  Shamala Balan; Mohamed Azmi Ahmad Hassali; Vivienne S L Mak
Journal:  World J Pediatr       Date:  2018-09-14       Impact factor: 2.764

Review 3.  Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review.

Authors:  Joana Magalhães; António Teixeira Rodrigues; Fátima Roque; Adolfo Figueiras; Amílcar Falcão; Maria Teresa Herdeiro
Journal:  Eur J Clin Pharmacol       Date:  2014-10-16       Impact factor: 2.953

Review 4.  Ethics of drug research in the pediatric intensive care unit.

Authors:  Niina Kleiber; Krista Tromp; Miriam G Mooij; Suzanne van de Vathorst; Dick Tibboel; Saskia N de Wildt
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

5.  Drug utilisation and off-label use of medications in anaesthesia in surgical wards of a teaching hospital.

Authors:  Amol E Patil; Yashashri C Shetty; Snehalata V Gajbhiye; Sweta V Salgaonkar
Journal:  Indian J Anaesth       Date:  2015-11

6.  The Unlicensed and Off-label Prescription of Medications in General Paediatric Ward: An Observational Study.

Authors:  Alícia Dorneles Dornelles; Lisiane Hoff Calegari; Lucian de Souza; Patrícia Ebone; Tiago Silva Tonelli; Clarissa Gutierrez Carvalho
Journal:  Curr Pediatr Rev       Date:  2019

7.  Effectiveness of α2agonists for sedation in paediatric critical care: study protocol for a retrospective cohort observational study.

Authors:  John C Hayden; Ian Dawkins; Cormac Breatnach; Finbarr P Leacy; June Foxton; Martina Healy; Gráinne Cousins; Paul J Gallagher; Dermot R Doherty
Journal:  BMJ Open       Date:  2017-05-30       Impact factor: 2.692

Review 8.  Review of Drug Utilization Studies in Neonatal Units: A Global Perspective.

Authors:  Asma Al-Turkait; Lisa Szatkowski; Imti Choonara; Shalini Ojha
Journal:  Int J Environ Res Public Health       Date:  2020-08-05       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.